TMCnet News

ORBCOMM Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of ORBCOMM Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - ORBC
[April 08, 2021]

ORBCOMM Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of ORBCOMM Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - ORBC


Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of ORBCOMM (News - Alert) Inc. (NASDAQ: ORBC) to GI Partners for $11.50 per share is fair to ORBCOMM shareholders.

Halper Sadeh encourages ORBCOMM shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

The investigation concerns whether ORBCOMM and its board of directors violated the federal securitis laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for ORBCOMM shareholders; (2) determine whether GI Partners is underpaying for ORBCOMM; and (3) disclose all material information necessary for ORBCOMM shareholders to adequately assess and value the merger consideration. On behalf of ORBCOMM shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.



Halper Sadeh encourages ORBCOMM shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.


Attorney Advertising. Prior results do not guarantee a similar outcome.


[ Back To TMCnet.com's Homepage ]